To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Diabetes: Medical Equipment
Tuesday 2nd July 2019

Asked by: Laura Smith (Labour - Crewe and Nantwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has any plans to reintroduce blood glucose test strips on prescription for Type 2 diabetics.

Answered by Seema Kennedy

Blood glucose test strips are available on prescription for people with type 2 diabetes. However, it is for clinical commissioning groups to make decisions on the commissioning of health services that best meet the needs of their local population, taking into account local priorities and needs.

The National Institute for Health and Care Excellence has published guidance on the management of type 2 Diabetes in adults. This guideline states:

“1.6.13 Do not routinely offer self-monitoring of blood glucose levels for adults with type 2 diabetes unless:

  • the person is on insulin or
  • there is evidence of hypoglycaemic episodes or
  • the person is on oral medication that may increase their risk of hypoglycaemia while driving or operating machinery or
  • the person is pregnant, or is planning to become pregnant. For more information, see the NICE guideline on diabetes in pregnancy (http://www.nice.org.uk/guidance/ng3 ). There have been no recent changes to prescribing recommendations, although NHS England have recently consulted on proposals to prescribe test strips only that fall below a certain cost threshold.”

More information is available at the following link:

https://www.nice.org.uk/guidance/ng28/chapter/1-Recommendations#blood-glucose-management-2


Written Question
Diabetes: Medical Equipment
Tuesday 2nd July 2019

Asked by: Laura Smith (Labour - Crewe and Nantwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure all Type 2 diabetics have access to a glucose monitoring blood test every three months as standard.

Answered by Seema Kennedy

Clinical commissioning groups are responsible for commissioning diabetes services for their local populations. They are also expected to take National Institute for Health and Care Excellence guidelines into consideration when making their decisions.


Written Question
Mental Health Services: Mothers
Tuesday 2nd July 2019

Asked by: Laura Smith (Labour - Crewe and Nantwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the adequacy of the identification of maternal mental health problems during maternal postnatal checks.

Answered by Jackie Doyle-Price

The Department has not made any such assessment.

NHS England is commissioning further work to establish a clearer picture of current practice.


Written Question
Mental Health Services: Mothers
Tuesday 2nd July 2019

Asked by: Laura Smith (Labour - Crewe and Nantwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the role of GPs in identifying and treating perinatal mental health problems in mothers.

Answered by Jackie Doyle-Price

The Department has not made any such assessment.


Written Question
Mental Health Services: Mothers
Tuesday 2nd July 2019

Asked by: Laura Smith (Labour - Crewe and Nantwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve outcomes for children by identifying and supporting new mothers with mental health problems.

Answered by Jackie Doyle-Price

This Government is committed to preventing mental illness and improving health outcomes for new parents and their children. The NHS Long Term Plan includes a commitment for a further 24,000 women to be able to access specialist perinatal mental health care by 2023/24, building on the additional 30,000 women who will access these services each year by 2020/21 under pre-existing plans.

From April 2019, new and expectant parents are able to access specialist perinatal mental health community services across England. Specialist care will also be available from preconception to 24 months after birth, which will provide an extra year of support (care is currently provided from preconception to 12 months after birth).


Speech in Westminster Hall - Mon 10 Jun 2019
Cystic Fibrosis Drugs: Orkambi

"It is a pleasure to serve under your chairmanship in this hugely important debate, Mr Hanson. I thank all the constituents who signed the petition, and those in the Public Gallery.

I am not surprised that my constituency featured so high up on the list of respondents, because my constituent, …..."

Laura Smith - View Speech

View all Laura Smith (Lab - Crewe and Nantwich) contributions to the debate on: Cystic Fibrosis Drugs: Orkambi

Speech in Westminster Hall - Mon 10 Jun 2019
Cystic Fibrosis Drugs: Orkambi

"It is great to hear my hon. Friend’s response. It seems perverse to me that the interests of big pharmaceutical companies can hold such enormous sway in this country, to the extent that cystic fibrosis sufferers can be left without their treatment—treatment that has the potential to prolong their lives …..."
Laura Smith - View Speech

View all Laura Smith (Lab - Crewe and Nantwich) contributions to the debate on: Cystic Fibrosis Drugs: Orkambi

Written Question
Medical Treatments: Prices
Wednesday 13th March 2019

Asked by: Laura Smith (Labour - Crewe and Nantwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent steps has he taken to ensure that medicines developed from public research are (a) accessible and (b) affordable.

Answered by Steve Brine

The National Institute for Health Research (NIHR) provides support for the development of new drugs, medical devices, diagnostics and treatments, primarily through its investment in research infrastructure in the National Health Service and through a range of research funding programmes. NIHR-supported research supports the early translational and clinical development of new medicines and generates high quality evidence which is made available to inform decisions about the NHS and patients on the effectiveness and cost-effectiveness of medicines, including through National Institute for Health and Care Excellence (NICE) guidance.

NICE technology appraisal guidance, and the associated funding requirement, play an important role in ensuring that patients have access to cost-effective new medicines, including medicines developed from public research. NICE assesses important new medicines through a robust evaluation process.

The Accelerated Access Review made recommendations to get transformative drugs and treatments to patients faster, while ensuring that the NHS gets value for money and remains at the forefront of innovation.

We have also formed the Accelerated Access Collaborative to accelerate patient access to high performing innovations that meet NHS needs.

The NHS is required by law to ensure that medicines recommended by NICE are routinely funded within three months, ensuring patient access to cost-effective medicines in England. There is no explicit link between the terms of NIHR research grants and the price the NHS pays for medicines.

The Department ensures that branded medicines remain affordable to the NHS through two pricing schemes. One is the 2019 Voluntary Scheme for Branded Medicines Pricing and Access (2019 Voluntary Scheme) and the other is the statutory scheme set out in legislation.


Written Question
Carers
Wednesday 13th March 2019

Asked by: Laura Smith (Labour - Crewe and Nantwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps the Government is taking to help ensure the safety of people procuring services of self-employed carers.

Answered by Caroline Dinenage

Many people procure the services of self-employed carers via their social care personal budget. A personal budget is an agreed amount of money allocated by a local authority to an individual receiving care, following an assessment of their care and support need.

Personal budgets enable individuals to purchase care services from a provider of their choice, in line with their agreed care plan. This may include employing self-employed carers such as personal assistants. Regulations do not require personal assistants to be registered with the Care Quality Commission. Local authorities are required to provide the level of support the individual wants when purchasing any care.

There is much advice and published guidance already available to support individuals when making decisions on procuring services of self-employed carers; for example, encouraging individuals who employ self-employed carers to consider asking for Disclosure and Barring Service checks, prior to employment. We have also commissioned Skills for Care and Think Local Act Personal to produce a range of additional support materials for those requiring care.


Written Question
Health Professions: Vetting
Tuesday 12th March 2019

Asked by: Laura Smith (Labour - Crewe and Nantwich)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if the Government will take steps to ensure that all people providing care can be subject to regulation and an enhanced DBS check.

Answered by Stephen Hammond

All people providing care remain subject to employer checks and controls and employers in the health and care sector must satisfy certain legal duties regarding the skills and competence of their staff. Disclosure and Barring Service checks (DBS checks) are only one means of providing employers with the necessary assurances about a workers’ suitability for a particular role. Employers are legally required to ensure that all workers in a regulated activity with adults and/or children are subject to a relevant enhanced DBS check with a view to preventing people from entering the workforce and undertaking a role from which they are barred from engaging in.

The Government is committed to a proportionate system of safeguards for the professionals who work in the health and care system. We are very clear that statutory professional regulation should only be used in cases where the risks to the public cannot be mitigated in other ways. We have no plans to make an assessment of the potential merits of a national registration and accreditation system for care workers in England at this time.